Skip to main content
. 2018 Mar 24;20(9):1215–1224. doi: 10.1093/neuonc/noy047

Table 5.

Ambulation

N (%)
Surveys
 y/n 11 (65)
 ECOG 9 (53)
 ODI 6 (35)
 mJOA 2 (12)
 GSTSG 1 (6)
 Nurick 1 (6)
 4 step 1 (6)
 10 meter 1 (6)
Ongoing Clinical Trials
 ECOG/Zubrod 15 (48)
 y/n 5 (16)